Vijay Aggarwal
Board Member
Vijay has over thirty years of senior management experience in both pharmaceutical services and clinical diagnostics. He is currently Managing Partner of The Channel Group, LLC and its affiliate, CoView Capital, a New York-based life sciences venture development and management firm. He is also an active member of the New York Angels and the Broad Street Angels.
Most recently, Dr. Aggarwal was President and CEO of Aureon Laboratories, Inc., a predictive pathology company offering advanced tissue analysis services to practicing physicians and the pharmaceutical industry. Previously, Dr. Aggarwal was President of Quest Diagnostic Ventures, where he had responsibility for new technology, new business models, clinical trials testing, and direct–to-consumer strategies.
He serves of the Boards of Allergenis, Genisphere, Accugenomics and is an advisor to Slone Partners.
Earlier in his career, Dr. Aggarwal held many positions with SmithKline Beecham Clinical Laboratories, including direct responsibility for all of SBCL’s U.S.-based laboratories as Executive Vice President of Laboratories, for reimbursement as Vice President of Managed Care and as a Vice President in the Healthcare Services division of SmithKline Beecham.
He earned a BA in Chemistry from Case Western Reserve University and a Ph.D. in Pharmacology/Toxicology from the Medical College of Virginia.
